Skip to content
Search

Latest Stories

PSNC appoints Robbie Turner as chief transformation officer

The Pharmaceutical Services Negotiating Committee (PSNC) has appointed Robbie Turner as chief transformation officer, to work closely with LPCs as part of its newly launched Transforming Pharmacy Representation (TAPR) programme.

PSNC launched the TAPR Programme in response to the contractor vote in favour of the Review Steering Group’s proposals. As part of the programme – alongside actioning the recommendations for PSNC – there will be support for LPCs to implement their proposals.


Turner will be responsible for leading, driving, and having oversight of the TAPR workstream to increase efficiency and outcomes across the network of LPCs in England.

This will include the provision of specialist hands-on guidance and support to LPC members and officers, to promote implementation of the RSG proposals, best practice and challenging the status quo.

Turner was formerly chief officer of Community Pharmacy West Yorkshire LPC and subsequently Director for England and Director of Pharmacy and Member Experience at the Royal Pharmaceutical Society.

PSNC says this appointment is a significant step in TAPR work – contractors can expect further updates in the coming weeks as well as a more detailed action plan by the end of September.

Commenting on his new role, Turner, PSNC chief transformation officer, said: “I’m delighted to be joining PSNC at this exciting time for PSNC, the LPCs and the community pharmacy sector. I’m looking forward to working closely with many of my former colleagues in LPCs again. There is much to be done at a local level to implement the RSG proposals and I will be reaching out to LPCs very soon about how I can support them through this process.”

James Wood, PSNC director of Contractor and LPC Support, said: “We’re really excited to have Robbie joining us at this critical point for LPCs and PSNC as we look to make positive changes following the outcomes of the RSG work. Robbie brings a huge amount of experience, enthusiasm, and credibility to this piece of work. He will be well known to many in pharmacy, and his experience in bringing together LPCs for the benefit of contractors in Yorkshire will be invaluable to other LPCs as they look to the changes ahead.”

On the 4 March 2022, RPS announced that Robbie Turner had decided to leave his role as director of Pharmacy and Membership Experience at the Society. His last day in RPS was 31 March 2022.

More For You

Operation Subaru:

Some of the medicines seized in raids today. Credit: MHRA

12 arrested in MHRA’s biggest medicines trafficking crackdown

Twelve people have been arrested in a series of dawn raids across the West Midlands and the Northwest of England today (29 April), as part of the biggest criminal investigation ever undertaken by the Medicines and Healthcare products Regulatory Agency (MHRA) into organised medicines trafficking.

The suspects were detained on suspicion of involvement in organised crime, conspiracy to sell or supply controlled and unlicensed medicines, and money laundering.

Keep ReadingShow less
Sukhi Basra named NPA vice-chair in historic leadership update with Olivier Picard as new chair

Olivier Picard steps up as NPA chair, Basra as vice-chair

Olivier Picard named new NPA chair

The National Pharmacy Association (NPA) has announced Olivier Picard as the organisation’s new chair.

Picard replaces Nick Kaye whose term comes to an end this week.

Keep ReadingShow less
 RPS honours Professor Tony Avery OBE for excellence in prescribing safety and patient care

Professor Tony Avery OBE

Pic credit: RPS

Professor Tony Avery OBE awarded RPS Honorary Fellowship

The Royal Pharmaceutical Society (RPS) Assembly has awarded an Honorary Fellowship to Professor Tony Avery OBE in recognition of his outstanding contribution to prescribing safety and patient care.

The Honorary Fellowship is given to those who are not eligible for membership of the Society but have either attained a distinction in a particular aspect or aspects of pharmacy, made a distinctive contribution to pharmacy or the RPS, distinguished themselves in any branches of knowledge referred to in the objects of the Society or achieved eminence in public life.

Keep ReadingShow less
US-UK pharmaceutical trade concerns as Liberal Democrat MPs urge protection from Trump tariffs.

UK prime minster Sir Keir Starmer with US president Donald Trump

Pic credit: Getty images

Pharma sector needs protecting from Trump tariffs, warn MPs

A group of Liberal Democrat MPs have written to health secretary Wes Streeting urging him to protect the pharmaceutical industry from US president Donald Trump’s trade war.

The five ministers from Oxfordshire, Olly Glover, Layla Moran, Calum Miller, Charlie Maynard, and Freddie van Mierlo, have warned that Trump’s campaign to raise tariffs has already led to “catastrophic damage”.

Keep ReadingShow less
Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less